The pathology of familial breast cancer. How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?

被引：17

作者：

Bertwistle D. ^{[1
]}

Ashworth A. ^{[1
]}

机构：

[1] The Breakthrough Toby Robins, Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road

来源：

Breast Cancer Research | / 1卷 / 1期

关键词：

BRCA1; BRCA2; Breast cancer; Cell cycle checkpoints; DNA repair; Gene expression;

D O I：

10.1186/bcr12

中图分类号：

学科分类号：

摘要：

Women with mutations in the breast cancer susceptibility genes, BRCA1 and BRCA2, have an increased risk of developing breast cancer. Both BRCA1 and BRCA2 are thought to be tumour suppressor genes since the wild type alleles of these genes are lost in tumours from heterozygous carriers. Several functions have been proposed for the proteins encoded by these genes which could explain their roles in tumour suppression. Both BRCA1 and BRCA2 have been suggested to have a role in transcriptional regulation and several potential BRCA1 target genes have been identified. The nature of these genes suggests that loss of BRCA1 could lead to inappropriate proliferation, consistent with the high mitotic grade of BRCA1-associated tumours. BRCA1 and BRCA2 have also been implicated in DNA repair and regulation of centrosome number. Loss of either of these functions would be expected to lead to chromosomal instability, which is observed in BRCA1 and BRCA2-associated tumours. Taken together, these studies give an insight into the pathogenesis of BRCA-associated tumours and will inform future therapeutic strategies.

引用

页码：41 / 47

共 65 条

[51]

Lee, H., Trainer, A.H., Friedman, L.S., Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2 (1999) Mol Cell, 4, pp. 1-10

[52]

Ludwig, T., Chapman, D.L., Papaioannou, V.E., Efstratiadis, A., Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53 and Brca2/p53 nullizygous embryos (1997) Genes Dev, 11, pp. 1226-1241

[53]

Crook, T., Crossland, S., Crompton, M.R., Osin, P., Gusterson, B.A., P53 mutations in BRCA1-associated familial breast cancer (1997) Lancet, 350, pp. 638-639

[54]

Crook, T., Brooks, L.A., Crossland, S., P53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours (1998) Oncogene, 17, pp. 1681-1689

[55]

Xu, X., Weaver, Z., Linke, S.P., Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells (1999) Mol Cell, 3, pp. 389-395

[56]

Larson, J.S., Tonkinson, J.L., Lai, M.T., A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells (1997) Cancer Res, 57, pp. 3351-3355

[57]

Hardwick, K.G., The spindle checkpoint (1998) Trends Genet, 14, pp. 1-4

[58]

Zimmerman, W., Sparks, C.A., Doxsey, S.J., Amorphous no longer: The centrosome comes into focus (1999) Curr Opin Cell Biol, 11, pp. 122-128

[59]

Tutt, A., Gabriel, A., Bertwistle, D., Absence of BRCA2 causes genome instability by chromosome breakage and loss associated with centrosome amplification (1999) Curr Biol, 9, pp. 1107-1110

[60]

Sluder, G., Thompson, E.A., Miller, F.J., Hayes, J., Rieder, C.L., The check-point control for anaphase onset does not monitor excess numbers of spindle poles or bipolar spindle symmetry (1997) J Cell Sci, 110, pp. 421-429

← 1 2 3 4 5 6 7 →